Sensitivity to Acute Cerebral Ischemia in Migrainers

Active, not recruitingOBSERVATIONAL
Enrollment

605

Participants

Timeline

Start Date

February 9, 2018

Primary Completion Date

March 6, 2023

Study Completion Date

July 31, 2024

Conditions
Ischemic StrokeMigraineMigraine With Aura
Interventions
OTHER

questionnaire ef-ID Migraine

"All consecutive patients eligible to the study will be included within 7 days of their initial admission, and evaluated with a short questionnaire classifying them as migrainers whose status will undergo a detailed validation at 3 months by a migraine expert, and non-migrainers whose status will be validated by repeating the short questionnaire at the follow-up visit at 3 months.~Initial multimodal imaging, done routinely in any stroke patient, will acquire the raw data necessary to calculate the mismatch ratio (MRI DWI/PWI or CT rCBF/CTP). All radiological data will be analyzed centrally after the end of the recruitment, by investigators blinded to the migraine status."

Trial Locations (1)

Unknown

CHU de Montpellier - Neurology Departement, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03301441 - Sensitivity to Acute Cerebral Ischemia in Migrainers | Biotech Hunter | Biotech Hunter